GSK2292767

CAS : 1254036-66-2

Ref. 3D-EAC03666

Informations sur le produit

• Nom: GSK2292767
• Marque: Biosynth
• Description: GSK2292767 is a small molecule that inhibits the protein kinase PI3Kδ. This inhibition blocks the activation of downstream proteins, including epidermal growth factor receptor (EGFR), which are involved in cell maturation and cancer. GSK2292767 has been shown to inhibit the growth of cancer cells in vitro and to reverse certain symptoms in animal models for autoimmune diseases. The drug has also been found to be effective against colorectal cancer and melanoma when used at an effective dose. GSK2292767 targets EGFR, which is important for cell maturation, proliferation, and apoptosis. It also inhibits the activity of PI3Kδ, which leads to the production of inflammatory cytokines by immune cells.; GSK2292767 is currently undergoing clinical trials as a treatment for certain types of cancer.

Propriétés chimiques

• Masse moléculaire: 512.58 g/mol
• Formule: C₂₄H₂₈N₆O₅S
• Degré de pureté: Min. 95%